Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Income (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) posted quarterly Non Operating Income of $64351.0 for Q1 2026, up 163.23% year-over-year from $24446.3 in Q1 2025, and down 62.88% quarter-over-quarter from $173340.0 in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Income (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Non Operating Income history runs 6 years deep, the most recent figure standing at $64351.0 for Q1 2026.
- In Q1 2026, Non Operating Income rose 163.23% year-over-year to $64351.0; the TTM figure through Mar 2026 stood at $361272.0 (up 130.0% YoY), while the FY2025 annual figure was $195155.0, up 113.47% from the prior year.
- Non Operating Income for Q1 2026 stood at $64351.0, down from $173340.0 in the prior quarter.
- The five-year high for Non Operating Income was $569683.0 in Q1 2023, with the low at -$2.2 million in Q4 2022.
- The 5-year median for Non Operating Income is -$176957.0 (2022), against an average of -$267159.1.
- The sharpest annual moves came in 2022 and 2023: Non Operating Income tumbled 803.47% in 2022, then soared 1411.33% in 2023.
- Shuttle Pharmaceuticals Holdings' Non Operating Income stood at -$2.2 million in 2022, then jumped by 83.65% to -$357676.0 in 2023, then jumped by 149.95% to $178659.0 in 2024, then retreated by 2.98% to $173340.0 in 2025, then plunged by 62.88% to $64351.0 in 2026.
- Business Quant data shows SHPH's Non Operating Income at $64351.0 in Q1 2026, $173340.0 in Q4 2025, and -$80360.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Shuttle Pharmaceuticals Holdings | 1.89 Mn | 1.89 Mn | - | 64,351.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,351.00 |
| Dec 31, 2025 | 173,340.00 |
| Sep 30, 2025 | -80,360.00 |
| Jun 30, 2025 | 203,941.00 |
| Mar 31, 2025 | -101,766.00 |
| Dec 31, 2024 | 178,659.00 |
| Sep 30, 2024 | -732,521.00 |
| Jun 30, 2024 | -548,581.00 |
| Mar 31, 2024 | -346,184.00 |
| Dec 31, 2023 | -357,676.00 |
| Sep 30, 2023 | -193,608.00 |
| Jun 30, 2023 | -718,740.00 |
| Mar 31, 2023 | 569,683.00 |
| Dec 31, 2022 | -2.19 Mn |
| Sep 30, 2022 | -176,957.00 |
| Jun 30, 2022 | -243,649.00 |
| Mar 31, 2022 | -43,443.00 |
| Dec 31, 2021 | 529,491.00 |
| Sep 30, 2021 | 25,155.00 |